Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Northwest Biotherapeutics ( (NWBO) ) just unveiled an announcement.
On November 14, 2025, Northwest Biotherapeutics entered into a $5 million convertible promissory note financing with YA II PN, Ltd., managed by Yorkville Advisors Global, LP. The funds will be used for construction and equipment costs for a manufacturing suite in Sawston, UK, and ongoing operations. The note has a 12-month term with no payments until maturity, a 5% original issue discount, and is convertible at a discount to the market price, with conversion limits unless the price exceeds $0.29.
More about Northwest Biotherapeutics
Average Trading Volume: 3,545,478
Technical Sentiment Signal: Strong Sell
Current Market Cap: $366.4M
Find detailed analytics on NWBO stock on TipRanks’ Stock Analysis page.